shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Influenza Modeling and Forecasting

    CDC-RFA-IP-25-0120

    Justin Lushbaugh

    Opening date 1 Aug 2024, 12:00AM

    Closing date N/A

    Funding Opportunity Number: CDC-RFA-IP-25-0120

    Opportunity Category: Discretionary

    Expected Number of Awards: 6

    CFDA Number(s): 93.185 -- Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects

    Cost Sharing or Matching Requirement: No

    Posted Date: Aug 01, 2024 12:00:00 AM EDT

    Closing Date: N/A

    Estimated Total Program Funding: 11250000

    Eligible Applicants: Special district governments,For profit organizations other than small businesses,State governments,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Independent school districts,Private institutions of higher education,County governments,Public housing authorities/Indian housing authorities,Native American tribal organizations (other than Federally recognized tribal governments),Native American tribal governments (Federally recognized),City or township governments,Others (see text field entitled "Additional Information on Eligibility" for clarification),Public and State controlled institutions of higher education,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

    Additional Information on Eligibility: N/A

    Description: The purpose of this Notice of Funding Opportunity is to establish a Network that will improve CDC’s use of influenza modeling and forecasting to provide situational awareness, inform prevention and control of influenza, advance the science of influenza forecasting and modeling, and increase communication of related results with public health officials. These efforts will help inform strategies to mitigate influenza morbidity and mortality, including in disproportionately affected populations, which include those with historically lower uptake and access to mitigation measures such as vaccination and antivirals.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept